Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 632

1.

The future of mesothelioma treatment: time to shift gear.

Maio M, Calabrò L.

Lancet Respir Med. 2019 May 15. pii: S2213-2600(19)30171-7. doi: 10.1016/S2213-2600(19)30171-7. [Epub ahead of print] No abstract available.

PMID:
31103413
2.

Potential diagnostic and prognostic role of micro-environment in malignant pleural mesothelioma.

Salaroglio IC, Kopecka J, Napoli F, Pradotto M, Maletta F, Costardi L, Gagliasso M, Milosevic V, Ananthanarayanan P, Bironzo P, Tabbò F, Cartia CF, Passone E, Comunanza V, Ardissone F, Ruffini E, Bussolino F, Righi L, Novello S, Di Maio M, Papotti M, Scagliotti G, Riganti C.

J Thorac Oncol. 2019 May 9. pii: S1556-0864(19)30357-0. doi: 10.1016/j.jtho.2019.03.029. [Epub ahead of print]

3.

The Effects of Conflict on Fertility: Evidence From the Genocide in Rwanda.

Kraehnert K, Brück T, Di Maio M, Nisticò R.

Demography. 2019 May 6. doi: 10.1007/s13524-019-00780-8. [Epub ahead of print]

PMID:
31062199
4.
5.

How to measure a Hill-Sachs lesion: a systematic review.

Maio M, Sarmento M, Moura N, Cartucho A.

EFORT Open Rev. 2019 Apr 26;4(4):151-157. doi: 10.1302/2058-5241.4.180031. eCollection 2019 Apr. Review.

6.

Second-line treatment options in hepatocellular carcinoma.

Marino D, Zichi C, Audisio M, Sperti E, Di Maio M.

Drugs Context. 2019 Apr 10;8:212577. doi: 10.7573/dic.212577. eCollection 2019. Review.

7.
8.

High Prevalence of Proarrhythmic Events in Patients With History of Atrial Fibrillation Undergoing a Rhythm Control Strategy: A Retrospective Study.

De Vecchis R, Di Maio M, Noutsias M, Rigopoulos AG, Ariano C, Di Biase G.

J Clin Med Res. 2019 May;11(5):345-352. doi: 10.14740/jocmr3805. Epub 2019 Apr 14.

9.

NK- and T-cell subsets in malignant mesothelioma patients: Baseline pattern and changes in the context of anti-CTLA-4 therapy.

Sottile R, Tannazi M, Johansson MH, Cristiani CM, Calabró L, Ventura V, Cutaia O, Chiarucci C, Covre A, Garofalo C, Pontén V, Tallerico R, Frumento P, Micke P, Maio M, Kärre K, Carbone E.

Int J Cancer. 2019 Apr 24. doi: 10.1002/ijc.32363. [Epub ahead of print]

PMID:
31018250
10.

Left Atrial Volume during Stress Is Associated with Increased Risk of Arrhythmias in Patients with Hypertrophic Cardiomyopathy.

Limongelli G, Fioretti V, Di Maio M, Verrengia M, Rubino M, Gravino R, Masarone D, D'Andrea A, Ciampi Q, Picano E, Elliott P, Pacileo G.

J Cardiovasc Echogr. 2019 Jan-Mar;29(1):1-6. doi: 10.4103/jcecho.jcecho_45_18.

11.

Successful implementation of infection control measure in a neonatal intensive care unit to combat the spread of pathogenic multidrug resistant Staphylococcus capitis.

Ory J, Cazaban M, Richaud-Morel B, Di Maio M, Dunyach-Remy C, Pantel A, Sotto A, Laurent F, Lavigne JP, Butin M.

Antimicrob Resist Infect Control. 2019 Mar 27;8:57. doi: 10.1186/s13756-019-0512-8. eCollection 2019.

12.

The role of patient-reported outcomes in outpatients receiving active anti-cancer treatment: impact on patients' quality of life.

Baratelli C, Turco CGC, Lacidogna G, Sperti E, Vignani F, Marino D, Zichi C, De Luca E, Audisio M, Ballaminut D, Bellezza A, Chiotto P, Ciriolo G, Comite R, Codegone F, Florio S, Fusco L, Polimeno L, Pozzi D, Zilio E, Terzolo S, Di Maio M.

Support Care Cancer. 2019 Apr 4. doi: 10.1007/s00520-019-04777-2. [Epub ahead of print]

PMID:
30949832
13.

Impact of lipoprotein(a) levels on recurrent cardiovascular events in patients with premature coronary artery disease.

Gragnano F, Fimiani F, Di Maio M, Cesaro A, Limongelli G, Cattano D, Calabrò P.

Intern Emerg Med. 2019 Mar 30. doi: 10.1007/s11739-019-02082-8. [Epub ahead of print] No abstract available.

PMID:
30929131
14.

Knowledge, attitudes and practice of physicians towards fertility and pregnancy-related issues in youngBRCA-mutated breast cancer patients.

Lambertini M, Di Maio M, Poggio F, Pagani O, Curigliano G, Mastro LD, Paluch-Shimon S, Loibl S, Partridge AH, Azim HA Jr, Peccatori FA, Demeestere I.

Reprod Biomed Online. 2019 May;38(5):835-844. doi: 10.1016/j.rbmo.2018.11.031. Epub 2019 Jan 10.

PMID:
30914152
15.

Long term control of luteinized thecoma with sclerosing peritonitis with leuprorelin and tamoxifen treatment.

Muratori L, Gorzegno G, Sperone P, Andreozzi A, Di Maio M, Scagliotti GV.

Gynecol Oncol Rep. 2019 Feb 16;28:44-46. doi: 10.1016/j.gore.2019.02.004. eCollection 2019 May.

16.

Genomic Features of Exceptional Response in Vemurafenib ± Cobimetinib-treated Patients with BRAF V600-mutated Metastatic Melanoma.

Yan Y, Wongchenko MJ, Robert C, Larkin J, Ascierto PA, Dréno B, Maio M, Garbe C, Chapman PB, Sosman JA, Shi Z, Koeppen H, Hsu JJ, Chang I, Caro I, Rooney I, McArthur GA, Ribas A.

Clin Cancer Res. 2019 Mar 1. doi: 10.1158/1078-0432.CCR-18-0720. [Epub ahead of print]

PMID:
30824584
17.

Therapeutic options for first-line metastatic castration-resistant prostate cancer: Suggestions for clinical practise in the CHAARTED and LATITUDE era.

Tucci M, Caffo O, Buttigliero C, Cavaliere C, D'aniello C, Di Maio M, Kinspergher S, Maines F, Rizzo M, Rossetti S, Veccia A, Scagliotti GV, Facchini G.

Cancer Treat Rev. 2019 Mar;74:35-42. doi: 10.1016/j.ctrv.2019.01.002. Epub 2019 Jan 7. Review.

PMID:
30738364
18.

Pericardial thrombus and cardiac tamponade after pericardiocentesis with intact heart walls.

Accadia M, Di Maio M, Iengo R, Arnese M, Cocchia R, Scotto Di Uccio F, Tuccillo A, Mercogliano G, Tuccillo B.

Echocardiography. 2019 Apr;36(4):803-805. doi: 10.1111/echo.14276. Epub 2019 Feb 6.

PMID:
30726561
19.

Reply to the letter to the editor 'On the underreporting of health-related quality of life and regulatory approval' by Bhamidipati et al.

Di Maio M, Marandino L, Perrone F.

Ann Oncol. 2019 Apr 1;30(4):658-659. doi: 10.1093/annonc/mdz035. No abstract available.

PMID:
30698648
20.

Immunomodulatory Properties of DNA Hypomethylating Agents: Selecting the Optimal Epigenetic Partner for Cancer Immunotherapy.

Fazio C, Covre A, Cutaia O, Lofiego MF, Tunici P, Chiarucci C, Cannito S, Giacobini G, Lowder JN, Ferraldeschi R, Taverna P, Di Giacomo AM, Coral S, Maio M.

Front Pharmacol. 2018 Dec 7;9:1443. doi: 10.3389/fphar.2018.01443. eCollection 2018.

21.

[Influenza vaccination in advanced cancer patients undergoing immunotherapy with anti-PD-1/PD-L1 immune checkpoint inhibitors: what data do we have for the clinical recommendation?]

Bersanelli M, Buti S, De Giorgi U, Di Maio M, Giannarelli D, Banna GL.

Recenti Prog Med. 2018 Nov;109(11):540-546. doi: 10.1701/3031.30291. Italian.

PMID:
30565573
22.

Addressing current challenges and future directions in immuno-oncology: expert perspectives from the 2017 NIBIT Foundation Think Tank, Siena, Italy.

Maio M, Coukos G, Ferrone S, Fox BA, Fridman WH, Garcia PL, Lahn M, Provendier O, Russo V, Rüttinger D, Shalabi A, Trajanoski Z, Viallet J, Wolchok JD, Ibrahim R.

Cancer Immunol Immunother. 2019 Jan;68(1):1-9. doi: 10.1007/s00262-018-2285-y. Epub 2018 Dec 18.

PMID:
30564889
23.

The Italian Network for Tumor Bio-Immunotherapy (NIBIT) Foundation: ongoing and prospective activities in immuno-oncology.

Di Giacomo AM, Covre A, Giacobini G, Ibrahim R, Lyman J, Natali PG, Maio M.

Cancer Immunol Immunother. 2019 Jan;68(1):143-150. doi: 10.1007/s00262-018-2286-x. Epub 2018 Dec 18. Review.

PMID:
30564888
24.

Hereditary Neuropathy with Liability to Pressure Palsies: A Rare Condition That Presents with Common Symptoms: A Case Report.

Mota PTD, Maio M, Sapage R, Branco C, Pintado C.

JBJS Case Connect. 2018 Oct-Dec;8(4):e95. doi: 10.2106/JBJS.CC.18.00132.

PMID:
30489379
25.

Publisher Correction: The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis.

Passiglia F, Rizzo S, Di Maio M, Galvano A, Badalamenti G, Listì A, Gulotta L, Castiglia M, Fulfaro F, Bazan V, Russo A.

Sci Rep. 2018 Nov 19;8(1):17270. doi: 10.1038/s41598-018-35524-y.

26.

Gender influence on professional satisfaction and gender issue perception among young oncologists. A survey of the Young Oncologists Working Group of the Italian Association of Medical Oncology (AIOM).

Dieci MV, Massari F, Giusti R, Inno A, Lombardi G, Noto L, Passaro A, Pietrantonio F, Spada F, Valente M, Di Maio M, Torri V.

ESMO Open. 2018 Oct 21;3(6):e000389. doi: 10.1136/esmoopen-2018-000389. eCollection 2018.

27.

Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions.

Tucci M, Zichi C, Buttigliero C, Vignani F, Scagliotti GV, Di Maio M.

Onco Targets Ther. 2018 Oct 24;11:7353-7368. doi: 10.2147/OTT.S153764. eCollection 2018. Review.

28.

Isolated neonatal bilateral vocal cord paralysis revealing a unilateral medullary defect: a case report.

Brotelande C, Leboucq N, Akkari M, Roujeau T, Di Maio M, Milési C, Mondain M, Raybaud C, Cambonie G.

BMC Pediatr. 2018 Nov 9;18(1):351. doi: 10.1186/s12887-018-1329-y.

29.

Collapse of the Plasmacytoid Dendritic Cell Compartment in Advanced Cutaneous Melanomas by Components of the Tumor Cell Secretome.

Vescovi R, Monti M, Moratto D, Paolini L, Consoli F, Benerini L, Melocchi L, Calza S, Chiudinelli M, Rossi G, Bugatti M, Maio M, Fonsatti E, Farisoglio C, Simbolo M, Almici C, Verardi R, Scarpa A, Bergese P, Manganoni A, Facchetti F, Vermi W.

Cancer Immunol Res. 2019 Jan;7(1):12-28. doi: 10.1158/2326-6066.CIR-18-0141. Epub 2018 Nov 6. Erratum in: Cancer Immunol Res. 2019 Apr;7(4):693.

PMID:
30401679
30.

Cons: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?

Metro G, Di Maio M.

Transl Lung Cancer Res. 2018 Sep;7(Suppl 3):S294-S296. doi: 10.21037/tlcr.2018.07.12. No abstract available.

31.

Cons: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?

Metro G, Di Maio M.

Transl Lung Cancer Res. 2018 Sep;7(Suppl 3):S290-S293. doi: 10.21037/tlcr.2018.07.11. No abstract available.

32.

Predictors of outcome in heart failure patients with severe functional mitral regurgitation undergoing MitraClip treatment.

Baldi C, Citro R, Silverio A, Di Maio M, De Rosa R, Bonadies D, Verolino G, Esposito L, Mastrogiovanni G, Di Muro MR, Piscione F, Galasso G.

Int J Cardiol. 2019 Jun 1;284:50-58. doi: 10.1016/j.ijcard.2018.10.055. Epub 2018 Oct 17.

PMID:
30360995
33.

Capecitabine plus temozolomide in well or moderately differentiated primary atypical neuroendocrine tumors: a single centre experience of two cases.

La Salvia A, Brizzi MP, Muratori L, Trevisi E, Di Maio M, Scagliotti GV.

Endokrynol Pol. 2018 Oct 25. doi: 10.5603/EP.a2018.0076. [Epub ahead of print]

34.

INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study.

Bersanelli M, Giannarelli D, Castrignanò P, Fornarini G, Panni S, Mazzoni F, Tiseo M, Rossetti S, Gambale E, Rossi E, Papa A, Cortellini A, Lolli C, Ratta R, Michiara M, Milella M, De Luca E, Sorarù M, Mucciarini C, Atzori F, Banna GL, La Torre L, Vitale MG, Massari F, Rebuzzi SE, Facchini G, Schinzari G, Tomao S, Bui S, Vaccaro V, Procopio G, De Giorgi U, Santoni M, Ficorella C, Sabbatini R, Maestri A, Natoli C, De Tursi M, Di Maio M, Rapacchi E, Pireddu A, Sava T, Lipari H, Comito F, Verzoni E, Leonardi F, Buti S.

Immunotherapy. 2018 Oct;10(14):1229-1239. doi: 10.2217/imt-2018-0080.

PMID:
30326787
35.

Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016.

Marandino L, La Salvia A, Sonetto C, De Luca E, Pignataro D, Zichi C, Di Stefano RF, Ghisoni E, Lombardi P, Mariniello A, Reale ML, Trevisi E, Leone G, Muratori L, Marcato M, Bironzo P, Novello S, Aglietta M, Scagliotti GV, Perrone F, Di Maio M.

Ann Oncol. 2018 Dec 1;29(12):2288-2295. doi: 10.1093/annonc/mdy449.

36.

Transcatheter Repair of Functional Mitral Regurgitation in Heart Failure Patients - A Meta-Analysis of 23 Studies on MitraClip Implantation.

De Rosa R, Silverio A, Baldi C, Di Maio M, Prota C, Radano I, Rey J, Herrmann E, Citro R, Piscione F, Galasso G.

Circ J. 2018 Oct 25;82(11):2800-2810. doi: 10.1253/circj.CJ-18-0571. Epub 2018 Sep 13.

37.

The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis.

Passiglia F, Rizzo S, Di Maio M, Galvano A, Badalamenti G, Listì A, Gulotta L, Castiglia M, Fulfaro F, Bazan V, Russo A.

Sci Rep. 2018 Sep 6;8(1):13379. doi: 10.1038/s41598-018-30780-4. Erratum in: Sci Rep. 2018 Nov 19;8(1):17270.

38.

Activation of immune responses in patients with relapsed-metastatic head and neck cancer (CONFRONT phase I-II trial): Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide.

Merlano MC, Merlotti AM, Licitra L, Denaro N, Fea E, Galizia D, Di Maio M, Fruttero C, Curcio P, Vecchio S, Russi EG, Corvò R.

Clin Transl Radiat Oncol. 2018 Aug 13;12:47-52. doi: 10.1016/j.ctro.2018.08.001. eCollection 2018 Aug.

39.

The BCY3/BCC 2017 survey on physicians' knowledge, attitudes and practice towards fertility and pregnancy-related issues in young breast cancer patients.

Lambertini M, Di Maio M, Pagani O, Curigliano G, Poggio F, Del Mastro L, Paluch-Shimon S, Loibl S, Partridge AH, Demeestere I, Azim HA Jr, Peccatori FA.

Breast. 2018 Dec;42:41-49. doi: 10.1016/j.breast.2018.08.099. Epub 2018 Aug 22.

PMID:
30170202
40.

Metastatic Renal Medullary Carcinoma Treated With Immune Checkpoint Inhibitor: Case Report and Literature Review.

Di Stefano RF, Buttigliero C, De Luca E, Reale ML, Pisano C, Leone G, Zichi C, Massa F, Manfredi M, Vignani F, Bollito E, Porpiglia F, Di Maio M, Tucci M.

Clin Genitourin Cancer. 2018 Dec;16(6):e1087-e1090. doi: 10.1016/j.clgc.2018.07.011. Epub 2018 Jul 21. No abstract available.

PMID:
30122516
41.

Clinical implication of changes in body composition and weight in patients with early-stage and metastatic breast cancer.

Trestini I, Carbognin L, Monteverdi S, Zanelli S, De Toma A, Bonaiuto C, Nortilli R, Fiorio E, Pilotto S, Di Maio M, Gasbarrini A, Scambia G, Tortora G, Bria E.

Crit Rev Oncol Hematol. 2018 Sep;129:54-66. doi: 10.1016/j.critrevonc.2018.06.011. Epub 2018 Jun 21. Review.

PMID:
30097238
42.

Immune-checkpoint inhibitors in previously treated patients with advanced or metastatic urothelial carcinoma: A systematic review and meta-analysis.

Di Nunno V, De Luca E, Buttigliero C, Tucci M, Vignani F, Gatto L, Zichi C, Ardizzoni A, Di Maio M, Massari F.

Crit Rev Oncol Hematol. 2018 Sep;129:124-132. doi: 10.1016/j.critrevonc.2018.07.004. Epub 2018 Jul 19. Review.

PMID:
30097230
43.

Role of radiotherapy in improving activity of immune-modulating drugs in advanced renal cancer: Biological rationale and clinical evidences.

Buttigliero C, Allis S, Tucci M, Zichi C, Leone G, Di Stefano RF, Ruo Redda MG, Ricardi U, Scagliotti GV, Di Maio M, Filippi AR.

Cancer Treat Rev. 2018 Sep;69:215-223. doi: 10.1016/j.ctrv.2018.07.010. Epub 2018 Jul 20. Review.

PMID:
30096699
44.

Fifteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) on Cancer Bio-Immunotherapy, Siena, Italy, October 5-7, 2017.

Maio M, Lofiego MF, Fazio C, Cannito S, Chiarucci C, Giacobini G, Valente M, Tunici P, Covre A, Russo V.

Cancer Immunol Immunother. 2019 Jan;68(1):151-158. doi: 10.1007/s00262-018-2222-0. Epub 2018 Aug 9. No abstract available.

PMID:
30094463
45.

Long-term follow up of metastatic melanoma patients treated with Thymosin alpha-1: investigating immune checkpoints synergy.

Danielli R, Cisternino F, Giannarelli D, Calabrò L, Camerini R, Savelli V, Bova G, Dragonetti R, Di Giacomo AM, Altomonte M, Maio M.

Expert Opin Biol Ther. 2018 Jul;18(sup1):77-83. doi: 10.1080/14712598.2018.1494717.

PMID:
30063847
46.

A review of guidelines for lung cancer.

Bironzo P, Di Maio M.

J Thorac Dis. 2018 May;10(Suppl 13):S1556-S1563. doi: 10.21037/jtd.2018.03.54. Review.

47.

Immune checkpoint blockade therapy of mesothelioma: a clinical and radiological challenge.

Calabrò L, Morra A, Cornelissen R, Aerts J, Maio M.

Cancer Immunol Immunother. 2018 Aug;67(8):1317-1324. doi: 10.1007/s00262-018-2191-3. Epub 2018 Jun 26. Review.

PMID:
29943157
48.

Reference Ranges and Physiologic Variations of Left E/e' Ratio in Healthy Adults: Clinical and Echocardiographic Correlates.

D'Andrea A, Vriz O, Ferrara F, Cocchia R, Conte M, Di Maio M, Driussi C, Scarafile R, Martone F, Sperlongano S, Tocci G, Citro R, Caso P, Bossone E, Golino P.

J Cardiovasc Echogr. 2018 Apr-Jun;28(2):101-108. doi: 10.4103/jcecho.jcecho_57_17.

49.

Chemotherapy-Induced Neutropenia and Outcome in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With First-Line Docetaxel.

Buttigliero C, Tucci M, Vignani F, Di Stefano RF, Leone G, Zichi C, Pignataro D, Lacidogna G, Guglielmini P, Numico G, Scagliotti GV, Di Maio M.

Clin Genitourin Cancer. 2018 Aug;16(4):318-324. doi: 10.1016/j.clgc.2018.05.006. Epub 2018 Jun 1.

PMID:
29866495
50.

Tremelimumab combined with durvalumab in patients with mesothelioma (NIBIT-MESO-1): an open-label, non-randomised, phase 2 study.

Calabrò L, Morra A, Giannarelli D, Amato G, D'Incecco A, Covre A, Lewis A, Rebelatto MC, Danielli R, Altomonte M, Di Giacomo AM, Maio M.

Lancet Respir Med. 2018 Jun;6(6):451-460. doi: 10.1016/S2213-2600(18)30151-6. Epub 2018 May 15.

PMID:
29773326

Supplemental Content

Support Center